Navigation Links
Access MediQuip's Rapid Response To Medtronic Infusion Pump Recall Protects Patients
Date:7/24/2013

Lake Mary, FL (PRWEB) July 24, 2013

Access MediQuip, the nation's first and largest surgical and implant management company, announced today that its industry leading Recall Management Service? (RMS) is helping protect patients nationwide following Class I recalls of a Medtronic infusion pump. Access MediQuip notified its payer partners immediately of the formal recalls of Medtronic's SynchroMed II Implantable Infusion Pump and identified which members were affected.

In June, Medtronic issued four medical device notifications about flaws with the SynchroMed infusion pumps, which are used to deliver pain and other medications. The flaws in the implant are linked to 14 patient deaths over 17 years. The U.S. Food and Drug Administration classified three of the notifications as Class I recalls, indicating the implantable device may cause serious adverse health consequences, including death. The fourth notification was classified as a Class II recall, indicating the possibility of temporary or medically reversible adverse health consequences.

"When there's a surgical device recall such as Medtronic's, speed and precision is essential to protecting patients, especially with Class I and II recalls when a patient's life and safety is at stake," said Prakash Patel, MD, CEO of Access MediQuip. "RMS accelerates the delivery of recall notices to health plans, physicians, facilities, manufacturers, and patients."

When a recall is initiated, RMS leverages Access MediQuip's expansive database of facility, device, and case-related information to identify potentially affected patients through a series of reactive and proactive processes. This capability allows RMS to recognize patients who have already received a defective device and those currently scheduled to receive one. Access MediQuip provides its partners with this HIPAA-compliant corresponding case information, which includes member identification number, name of the facility where the procedure was or is to be performed, physician's name, serial number of the recalled implant, and date of service.

"Thanks to our RMS solution, we are able to provide our partners with the specific information they need concerning any implant recall and support their efforts to ensure patient safety," said Dr. Patel. "There is no better recall management solution on the market, which is why so many payers, facilities, and physicians have made RMS their service of choice."

About Access MediQuip

Access MediQuip is the largest and only company in the country that provides an integrated, comprehensive surgical and implant management solution (SIMS) program. With more than 16 years of experience, Access MediQuip provides payers with analytics to understand their implant spend, manage and control the high costs of implants and surgeries, and improve the quality and safety of surgical procedures, all while maintaining full access and choice of implants for facilities, surgeons and, ultimately, patients. The company was founded in 1997 and is headquartered in Lake Mary, Florida. For more information, please visit http://www.accessmediquip.com.

###

Media Contact:
Lindsey Harris
lharris(at)accessmediquip(dot)com
713-978-4493

Read the full story at http://www.prweb.com/releases/2013/7/prweb10956266.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Image share project gives patients and physicians anytime, anywhere access to medical images
2. Equal access to care helps close survival gap for young African-American cancer patients
3. Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers
4. World Health Assembly endorses new plan to increase global access to vaccines
5. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
6. Researchers offer new approach to track former prisoners access to community HIV care
7. Revised geographic adjustments could improve accuracy of Medicare payments, will not solve access, quality problems
8. Access to clinical trials drives dramatic increases in survival from childhood cancer
9. Disabled Americans Battle for Access to Hotel Pools
10. Expanding Access to Medicaid Would Save Lives: Study
11. The ACCESS-EU study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... For over twenty-four years, Doctors on Liens has published a directory of the ... medical care. When the company started in 1997, the directory was a single page ... the now ten-page directory features a vast array of medical specialists stretching from ...
(Date:12/2/2016)... ... 02, 2016 , ... FlexiSpot, a trusted name in sit-stand ... program for all of the company’s desktop riser products. A simple application form ... , FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering system ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the ... how he was inspired to practice medicine at an early age by his father, ... than making diagnoses and prescribing medicine,” he states. “It is about building relationships with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a ... in the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. ... their education, experience, and professional associations. , One the most frequently honored ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, ... through labeling, storing, shipping and disposal. The new version is a faster and ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Md. , Dec. 2, 2016 The ... indication for Jardiance (empagliflozin) to reduce the risk of ... mellitus and cardiovascular disease. "Cardiovascular disease ... type 2 diabetes mellitus," said Jean-Marc Guettier , ... Endocrinology Products in FDA,s Center for Drug Evaluation and ...
(Date:12/2/2016)... the ECG Cables And ECG Leadwires Market owing to the ... On the other hand, the Asia-Pacific ... during the forecast period. The market players namely, ... ( Ireland ), Koninklijke Philips N.V. ( ... China ), held major share of the ECG ...
(Date:12/2/2016)... , December 2, 2016 ... Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), ... (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast ... is valued at USD 60.22 Billion in 2016. ... CAGR of 5.5% during the forecast period (2016-2021) ...
Breaking Medicine Technology: